We are calling on the Government of Canada to review the 2013 decision to classify alkyl nitrites (“poppers”) as unauthorized drugs, and to consider a safer, evidence-based regulatory approach.

While this policy was intended to protect public health, its real-world impact appears to have created unintended risks.

Demand for these products has not disappeared. Instead, the current framework has:

• Shifted sales to unregulated black-market sources
• Increased cross-border purchasing and informal importation
• Removed product labeling standards and quality control
• Increased exposure to higher-risk formulations, particularly isopropyl nitrite

Of particular concern is the growing presence of isopropyl nitrite products, which research has associated with eye damage (maculopathy), including blurred vision, blind spots, and in some cases long-term or permanent vision impairment. There are also concerns in scientific literature about potential carcinogenic effects.

Prior to 2013, products commonly available in Canada were more often pentyl nitrite formulations. While not risk-free, these were not associated with the same pattern of retinal injury now being reported with isopropyl nitrite products.

By removing regulated domestic availability, the current approach appears to have reduced oversight while increasing exposure to potentially more harmful substances.

This pattern is consistent with broader public health evidence: prohibition does not eliminate use, it shifts risk.

Regulatory context:

Canada already regulates a range of substances that carry potential risks but also have legitimate or secondary uses. These are managed through product standards, labeling requirements, and targeted restrictions rather than outright prohibition.

This approach recognizes that when demand exists, regulation is often more effective at reducing harm than removing oversight entirely.

This is reflected in areas such as consumer chemicals and other controlled products, where policy focuses on minimizing risk through standards, transparency, and education rather than eliminating access altogether.

Applying a similar evidence-based, risk-managed framework to alkyl nitrites would align with established public health practices in Canada.

We believe a modern, harm-reduction approach would better protect Canadians.

 
We are calling on the Government of Canada to:

• Conduct a formal review of the 2013 classification and enforcement approach
• Consider a regulated consumer product framework rather than effective prohibition
• Restrict or prohibit higher-risk formulations such as isopropyl nitrite
• Consult toxicologists, public health experts, and harm-reduction organizations
• Include input from LGBTQ+ communities, where these products have historically been more commonly use.

Why this petition matters:

This petition is intended to demonstrate that concern about this issue extends beyond a single individual.

By signing, you are helping show Members of Parliament that there is broader public interest in reviewing this policy. Once sufficient support is demonstrated, we will be asking MPs to sponsor a formal petition in the House of Commons so this issue can be properly reviewed at the federal level.

A quick note on how to strengthen this effort:

When sharing or commenting, framing this issue around public health and harm reduction helps it be taken more seriously by policymakers.

Language focused on safety, regulation, and evidence-based policy makes it more likely this issue will be reviewed and acted on.